Project Grant R24AR085003
Award Date
4/1/25
Completion Date
2/28/29
Dollars Obligated
$519K
Similar Awards
This federal Project Grant award of $533,151 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support the creation of a biomedical knowledgebase to promote and facilitate the use of the Osteoarthritis Initiative (OAI) data, which contains comprehensive clinical, imaging, and biospecimen data from over 4,796 individuals with or at risk of knee osteoarthritis.
The key...
This federal Project Grant award of $456,808 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskelastic and Skin Diseases Research program (CFDA 93.846), will fund the development of innovative mass spectrometry imaging (MSI) technologies to spatially visualize proteins and glycans in bone and cartilage tissue samples. The project aims to advance understanding of disease progression in osteoarthritis and meniscal injury by...
This federal Project Grant award, with ID R24AR084725, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The objective of this $522,334 award, with a period of performance from Sep 19, 2024 to Jul 31, 2028, is to develop a cloud-based biomedical data repository named "BoneBase" that will collect and share bone phenotyping data generated by national...
This $526,174 Project Grant was awarded on June 1, 2024 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funding will support Duke University's efforts to engineer and study heterocellular human skeletal muscle tissue models that incorporate key cellular components, such as capillary networks and functional motor neurons, to better recreate and investigate the native...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $732,272 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the Trustees of Indiana University, doing business as Indiana University Indianapolis. The grant, awarded on September 2, 2024, will fund the establishment of the ICMH Resource Cores (ICMH-RC) to promote and support advancements in musculoskeletal research. The ICMH-RC will consist of an...
This $483,070 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to better understand the dynamics of bone extracellular matrix assembly and resorption. The award to the University of Missouri at Kansas City will fund in vitro and in vivo imaging studies to examine how osteogenic cellular dynamics, differentiation, and cell...
This federal Project Grant award, valued at $172,766 and provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), aims to establish the utility of using real-time patient-reported and biometric data to prognosticate and stratify lumbar spine patients, and to define the value proposition for implementing these methods.
The key objectives of the 5-year project, funded under the NIAMS Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA...
This $599,693 five-year Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to elucidate molecular pathways and mechanisms regulating myeloid cell function and osteoclastogenesis under pathological inflammatory conditions. The overarching goal is to use this knowledge to develop new therapeutic approaches to suppress pathological bone resorption,...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $525,048 to support the development and optimization of skeletal muscle delivery vehicles. The goal is to explore the use of muscle-specific cell fusogens, such as myomaker and myomerger, to engineer lentiviruses and extracellular vesicles that can selectively target and...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $220,224 Project Grant with an effective date of Jul 4, 2024 and ultimate completion date of Aug 31, 2027. The grant, titled "GRANULAR HYDROGELS FOR THE CONTROLLED DELIVERY OF IMMUNOMODULATORY AND ANGIOGENIC EXTRACELLULAR VESICLES TO ENHANCE BONE TISSUE REGENERATION", will support research conducted by the University of Colorado to develop granular hydrogel-based therapies for controlled...